ANGELA PHAM: Open Payments
NPI 1972218543 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,525 in 114 payments from 20 companies in 2025. Trend: 2023 $968 · 2024 $1,780 · 2025 $2,525
Food & beverage: $2,525
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $330 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 16 | $258 |
| JAZZ PHARMACEUTICALS INC. | 10 | $226 |
| GENZYME CORPORATION | 8 | $201 |
| Regeneron Healthcare Solutions, Inc. | 11 | $179 |
| Actelion Pharmaceuticals US, Inc. | 6 | $171 |
| GlaxoSmithKline, LLC. | 13 | $166 |
| Viatris Specialty LLC | 9 | $160 |
| Verona Pharma, Inc. | 6 | $133 |
| ANI Pharmaceuticals, Inc. | 4 | $122 |
Products named: DUPIXENT, XYWAV, YUPELRI, FASENRA, OFEV, Ohtuvayre, BREZTRI, PURIFIED CORTROPHIN GEL.
Industry payments across FL — which companies pay providers there.
